BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30712886)

  • 21. Expression of variant luteinizing hormone/chorionic gonadotropin receptors and degradation of chorionic gonadotropin in human chorionic villous macrophages.
    Sonoda N; Katabuchi H; Tashiro H; Ohba T; Nishimura R; Minegishi T; Okamura H
    Placenta; 2005 Apr; 26(4):298-307. PubMed ID: 15823616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DPY30 is required for the enhanced proliferation, motility and epithelial-mesenchymal transition of epithelial ovarian cancer cells.
    Zhang L; Zhang S; Li A; Zhang A; Zhang S; Chen L
    Int J Mol Med; 2018 Dec; 42(6):3065-3072. PubMed ID: 30221689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Too much of a good thing? Experimental evidence suggests prolonged exposure to hCG is detrimental to endometrial receptivity.
    Evans J; Salamonsen LA
    Hum Reprod; 2013 Jun; 28(6):1610-9. PubMed ID: 23515188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between LH receptor regulation and ovarian hyperstimulation syndrome in a rodent model.
    Zheng C; Gulappa T; Menon B; Menon KMJ
    Reproduction; 2020 Aug; 160(2):239-245. PubMed ID: 32422603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperglycosylated hCG activates LH/hCG-receptor with lower activity than hCG.
    Koistinen H; Koel M; Peters M; Rinken A; Lundin K; Tuuri T; Tapanainen JS; Alfthan H; Salumets A; Stenman UH; Lavogina D
    Mol Cell Endocrinol; 2019 Jan; 479():103-109. PubMed ID: 30287399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The aryl hydrocarbon receptor is required for normal gonadotropin responsiveness in the mouse ovary.
    Barnett KR; Tomic D; Gupta RK; Babus JK; Roby KF; Terranova PF; Flaws JA
    Toxicol Appl Pharmacol; 2007 Aug; 223(1):66-72. PubMed ID: 17594909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study.
    Brunette LL; Mhawech-Fauceglia PY; Ji L; Skeate JG; Brand HE; Lawrenson K; Walia S; Chiriva-Internati M; Groshen S; Roman LD; Kast WM; Da Silva DM
    BMC Cancer; 2018 Oct; 18(1):970. PubMed ID: 30309325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ZYG11A Is Expressed in Epithelial Ovarian Cancer and Correlates With Low Grade Disease.
    Achlaug L; Somri-Gannam L; Meisel-Sharon S; Sarfstein R; Dixit M; Yakar S; Hallak M; Laron Z; Werner H; Bruchim I
    Front Endocrinol (Lausanne); 2021; 12():688104. PubMed ID: 34220714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. hCG: Biological Functions and Clinical Applications.
    Nwabuobi C; Arlier S; Schatz F; Guzeloglu-Kayisli O; Lockwood CJ; Kayisli UA
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
    Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
    Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specificity of cognate ligand-receptor interactions: fusion proteins of human chorionic gonadotropin and the heptahelical receptors for human luteinizing hormone, thyroid-stimulating hormone, and follicle-stimulating hormone.
    Schubert RL; Narayan P; Puett D
    Endocrinology; 2003 Jan; 144(1):129-37. PubMed ID: 12488338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Luteinizing hormone and human chorionic gonadotropin: origins of difference.
    Choi J; Smitz J
    Mol Cell Endocrinol; 2014 Mar; 383(1-2):203-13. PubMed ID: 24365330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of LH and FSH receptors after hCG and eCG treatments in the porcine oviduct.
    Małysz-Cymborska I; Andronowska A
    Domest Anim Endocrinol; 2016 Oct; 57():48-54. PubMed ID: 27565230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coexpression of human chorionic gonadotropin beta subunit and its receptor in nontrophoblastic gynecological cancer.
    Jankowska A; Andrusiewicz M; Grabowski J; Nowak-Markwitz E; Warchol JB
    Int J Gynecol Cancer; 2008; 18(5):1102-7. PubMed ID: 18217981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human ovarian surface epithelial (OSE) cells express LH/hCG receptors, and hCG inhibits apoptosis of OSE cells via up-regulation of insulin-like growth factor-1.
    Kuroda H; Mandai M; Konishi I; Tsuruta Y; Kusakari T; Kariya M; Fujii S
    Int J Cancer; 2001 Feb; 91(3):309-15. PubMed ID: 11169952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two Hormones for One Receptor: Evolution, Biochemistry, Actions, and Pathophysiology of LH and hCG.
    Casarini L; Santi D; Brigante G; Simoni M
    Endocr Rev; 2018 Oct; 39(5):549-592. PubMed ID: 29905829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gonadotropin-induced up- and down-regulation of rat ovarian LH receptor message levels during follicular growth, ovulation and luteinization.
    LaPolt PS; Oikawa M; Jia XC; Dargan C; Hsueh AJ
    Endocrinology; 1990 Jun; 126(6):3277-9. PubMed ID: 2351119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancing endometrial receptivity: the roles of human chorionic gonadotropin in autophagy and apoptosis regulation in endometrial stromal cells.
    Wang B; Gao M; Yao Y; Shen H; Li H; Sun J; Wang L; Zhang X
    Reprod Biol Endocrinol; 2024 Apr; 22(1):37. PubMed ID: 38576003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistence of biological activity of biotinylated human chorionic gonadotropin and its use for visualization of rat luteinizing hormone receptors in tissue sections.
    Paukku T; Ahtiainen P; Haavisto AM; Huhtaniemi IT
    J Histochem Cytochem; 1998 Sep; 46(9):993-8. PubMed ID: 9705964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of cyclase-associated actin cytoskeleton regulatory protein 2 in epithelial ovarian cancer correlates with aggressive histologic types and worse outcomes.
    Adachi M; Masugi Y; Yamazaki K; Emoto K; Kobayashi Y; Tominaga E; Banno K; Aoki D; Sakamoto M
    Jpn J Clin Oncol; 2020 Jun; 50(6):643-652. PubMed ID: 32211793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.